Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

Abroad (travel likely)RecruitingPHASE2

Conditions

Ulcerative Colitis (UC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Northwestern University, Chicago, Illinois, United States
Contact: Study coordinator (Parambir S. Dulai, MD) · parambir.dulai@northwestern.edu

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

LFMT vs Placebo in New Biologic Start for Ulcerative Colitis

Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE2

Edmonton, Canada

Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis (UC)

Abroad (travel likely)RecruitingPHASE2

Barnaul, Russia · Ufa, Russia

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC) · Ulcerative Colitis, Active Moderate · Ulcerative Colitis, Active Severe

IsraelRecruitingPHASE2

Phoenix, United States · Scottsdale, United States

Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

Ulcerative Colitis · Inflammatory Bowel Diseases · Clostridioides Difficile Infection

Abroad (travel likely)RecruitingPHASE1

Calgary, Canada · Edmonton, Canada